Stylianos A. Pyxaras1, MD, PhD; Alfredo R. Galassi2, MD, PhD; Gerald S. Werner3, MD, PhD; Alexandre Avran4, MD; Roberto Garbo5, MD; Omer Goktekin6, MD, PhD; Nicolas Boudou7, MD; Alexander Bufe8, MD; Georgios Sianos9, MD, PhD; Gabriele L. Gasparini10, MD; Alessio La Manna11, MD; Joachim Weber-Albers12, MD; Thierry Lefèvre13, MD; Gorgulu Sevket14, MD; David Hildick-Smith15, MD; Javier Escaned16, MD, PhD; Markus Meyer-Gessner17, MD; Leszek Bryniarski18,19, MD, PhD; Carlo Di Mario20, MD, PhD; Kambis Mashayekhi21, MD
1. Medizinische Klinik I, Klinikum Fürth, Fürth, Germany; 2. U.O.C. Cardiologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza (ProMISE) "G. D'Alessandro", A.O.U. Policlinico Paolo Giaccone, Università degli Studi, Palermo, Italy; 3. Medizinische Klinik I (Cardiology & Intensive Care), Klinikum Darmstadt GmbH, Darmstadt, Germany; 4. Department of Interventional Cardiology, Clinique Pasteur, Essey-lès-nancy, France; 5. Department of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy; 6. Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey; 7. Cardiology Department, University Hospital of Poitiers, Poitiers, France; 8. Department of Cardiology, Heart Centre Niederrhein, Helios Clinics Krefeld, Germany; 9. AHEPA University General Hospital of Thessaloniki, 1st Cardiology Department, Thessaloniki, Greece; 10. Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; 11. Division of Cardiology, C.A.S.T., Azienda Ospedaliero-Universitaria "Policlinico-S. Marco", University of Catania, Catania, Italy; 12. St. Johannes-Hospital, Dortmund, Germany; 13. Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France; 14. Department of Cardiology, Faculty of Medicine, Acıbadem University, Istanbul, Turkey; 15. Sussex Cardiac Centre, Brighton, United Kingdom; 16. Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain; 17. Klinik Kardiologie Augusta Krankenhaus, Düsseldorf, Germany; 18. Department of Cardiology and Cardiovascular Interventions, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland; 19. Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland; 20. Structural Interventional Cardiology, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy; 21. Division of Cardiology and Angiology II, University Heartcenter Freiburg - Bad Krozingen, Bad Krozingen, Germany
Dual lumen microcatheters (DLMC) have become indispensable tools in the setting of percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). Other than allowing preservation and treatment of bifurcated coronary branches within or in the proximity of the CTO body, they enable the use of modified parallel wiring, antegrade dissection and re-entry, collateral selection and retrograde negotiation of the distal CTO cap. This EuroCTO consensus document describes current DLMC and suggests a practical guide to anatomies and techniques in which these devices are applicable.
No account yet? Create my pcr account
Sign up for free!
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases
bifurcationother techniquechronic coronary total occlusion
Read next article
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score